Truly endothelial progenitor cells (EPCs) can be mobilized from bone marrow to support the vascular network of growing tumors, thereby sustaining the metastatic switch. Endothelial colony forming cells (ECFCs) are the only EPC subtype belonging to the endothelial phenotype and capable of incorporating within neovessels. The intracellular Ca2+ machinery plays a key role in ECFC activation and is remodeled in renal cellular carcinoma-derived ECFCs (RCC-ECFCs). Particularly, RCC-ECFCs seems to undergo a drop in endoplasmic reticulum (ER) Ca2+ concentration ([Ca2+]ER). This feature is remarkable when considering that inositol-1,4,5-trisphosphate (InsP3)-dependent ER-to-mitochondria Ca2+ transfer regulates the intrinsic apoptosis pathway. Herein, we sought to assess whether: (1) the [Ca2+]ER and the InsP3-induced ER-mitochondria Ca2+ shuttle are reduced in RCC-ECFCs; and (2) the dysregulation of ER Ca2+ handling leads to apoptosis resistance in tumor-derived cells. RCC-ECFCs displayed a reduction both in [Ca2+]ER and in the InsP3-dependent mitochondrial Ca2+ uptake, while they expressed normal levels of Bcl-2 and Bak. The decrease in [Ca2+]ER was associated to a remarkable ER expansion in RCC-ECFCs, which is a hallmark of ER stress, and did not depend on the remodeling of the Ca2+-transporting and the ER Ca2+-storing systems. As expected, RCC-ECFCs were less sensitive to rapamycin- and thapsigargin-induced apoptosis; however, buffering intracellular Ca2+ levels with BAPTA dampened apoptosis in both cell types. Finally, store-operated Ca2+ entry was seemingly uncoupled from the apoptotic machinery in RCC-ECFCs. Thus, the chronic underfilling of the ER Ca2+ pool could confer a survival advantage to RCC-ECFCs and underpin RCC resistance to pharmacological treatment. J. Cell. Biochem. 117: 2260–2271, 2016. © 2016 Wiley Periodicals, Inc.

Endoplasmic Reticulum Ca2+ Handling and Apoptotic Resistance in Tumor-Derived Endothelial Colony Forming Cells / V. Poletto, S. Dragoni, D. Lim, M. Biggiogera, A. Aronica, M. Cinelli, A. De Luca, V. Rosti, C. Porta, G. Guerra, F. Moccia. - In: JOURNAL OF CELLULAR BIOCHEMISTRY. - ISSN 0730-2312. - 117:10(2016 Oct), pp. 2260-2271. [10.1002/jcb.25524]

Endoplasmic Reticulum Ca2+ Handling and Apoptotic Resistance in Tumor-Derived Endothelial Colony Forming Cells

A. Aronica;
2016

Abstract

Truly endothelial progenitor cells (EPCs) can be mobilized from bone marrow to support the vascular network of growing tumors, thereby sustaining the metastatic switch. Endothelial colony forming cells (ECFCs) are the only EPC subtype belonging to the endothelial phenotype and capable of incorporating within neovessels. The intracellular Ca2+ machinery plays a key role in ECFC activation and is remodeled in renal cellular carcinoma-derived ECFCs (RCC-ECFCs). Particularly, RCC-ECFCs seems to undergo a drop in endoplasmic reticulum (ER) Ca2+ concentration ([Ca2+]ER). This feature is remarkable when considering that inositol-1,4,5-trisphosphate (InsP3)-dependent ER-to-mitochondria Ca2+ transfer regulates the intrinsic apoptosis pathway. Herein, we sought to assess whether: (1) the [Ca2+]ER and the InsP3-induced ER-mitochondria Ca2+ shuttle are reduced in RCC-ECFCs; and (2) the dysregulation of ER Ca2+ handling leads to apoptosis resistance in tumor-derived cells. RCC-ECFCs displayed a reduction both in [Ca2+]ER and in the InsP3-dependent mitochondrial Ca2+ uptake, while they expressed normal levels of Bcl-2 and Bak. The decrease in [Ca2+]ER was associated to a remarkable ER expansion in RCC-ECFCs, which is a hallmark of ER stress, and did not depend on the remodeling of the Ca2+-transporting and the ER Ca2+-storing systems. As expected, RCC-ECFCs were less sensitive to rapamycin- and thapsigargin-induced apoptosis; however, buffering intracellular Ca2+ levels with BAPTA dampened apoptosis in both cell types. Finally, store-operated Ca2+ entry was seemingly uncoupled from the apoptotic machinery in RCC-ECFCs. Thus, the chronic underfilling of the ER Ca2+ pool could confer a survival advantage to RCC-ECFCs and underpin RCC resistance to pharmacological treatment. J. Cell. Biochem. 117: 2260–2271, 2016. © 2016 Wiley Periodicals, Inc.
apoptosis; calcium signaling; cancer; endothelial progenitor cells; biochemistry; molecular biology; cell biology
Settore BIO/09 - Fisiologia
ott-2016
Article (author)
File in questo prodotto:
File Dimensione Formato  
Poletto_et_al-2016-Journal_of_Cellular_Biochemistry.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.37 MB
Formato Adobe PDF
1.37 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/471429
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 26
  • ???jsp.display-item.citation.isi??? 23
social impact